Brought to you by 
T2 Biosystems goes public netting $61.2mm
12 Aug 2014
Executive Summary
Diagnostics firm T2 Biosystems Inc. netted $61.2mm in its initial public offering of 5.98mm common shares (including the overallotment) at $11. The firm had planned to sell 4mm shares between $15 and $17.
Deal Industry
- In Vitro Diagnostics
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
-
Diagnostic Imaging Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Saliva-based Testing
- Urine-based Testing
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
T2 Biosystems goes public netting $61.2mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice